Ragasa, Ysrael Edrich M.

HRN: 27-27-35  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
06/26/2025
07/03/2025
IV
40mg - LD; 20mg - MD
Q12
PSNB
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines